Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens

被引：0

作者：

Lambert, LA ^{[1
]}

Ijaz, K ^{[1
]}

Navin, TR ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Div TB Eliminat, Dept Hlth & Human Serv, DTBE, Atlanta, GA 30333 USA

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2005年 / 9卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：230 / 230

页数：1

共 50 条

[1] Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamicle with isoniazid regimens
Lincoln, T
Brannan, GL
Lynch, V
Conklin, TJ
Clancey, T
Rose, DN
Tuthill, RJ
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (03) : 306 - 311
[2] TREATMENT OF TUBERCULOSIS WITH ISONIAZID, RIFAMPIN AND PYRAZINAMIDE
BRANDLI, O
DREHER, D
MORGER, D
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1993, 123 (25) : 1300 - 1306
[3] STABILITY OF ISONIAZID, RIFAMPIN AND PYRAZINAMIDE IN SUSPENSIONS USED FOR THE TREATMENT OF TUBERCULOSIS IN CHILDREN
SEIFART, HI
PARKIN, DP
DONALD, PR
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (11) : 827 - 831
[4] Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment
van Hest, R
Baars, H
Kik, S
van Gerven, P
Trompenaars, MC
Kalisvaart, N
Keizer, S
Borgdorff, M
Mensen, M
Cobelens, F
CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 488 - 496
[5] ISONIAZID-RIFAMPIN REGIMENS FOR TUBERCULOSIS
FARER, LS
LONG, MW
SNIDER, DE
ANNALS OF INTERNAL MEDICINE, 1981, 95 (04) : 518 - 519
[6] Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months
Nolan, CM
Goldberg, SV
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (11) : 952 - 958
[7] ISONIAZID-RIFAMPIN REGIMENS FOR TUBERCULOSIS - REPLY
BUECHNER, HA
ANNALS OF INTERNAL MEDICINE, 1981, 95 (04) : 519 - 519
[8] The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Akos Somoskovi
Linda M Parsons
Max Salfinger
Respiratory Research, 2
[9] The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Somoskovi, A
Parsons, LM
Salfinger, M
RESPIRATORY RESEARCH, 2001, 2 (03) : 164 - 168
[10] Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis
José Francisco García-Rodríguez
N. Valcarce-Pardeiro
H. Álvarez-Díaz
A. Mariño-Callejo
European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 2121 - 2126

← 1 2 3 4 5 →